Mindy Simpson

1.2k total citations
31 papers, 392 citations indexed

About

Mindy Simpson is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Mindy Simpson has authored 31 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in Mindy Simpson's work include Hemophilia Treatment and Research (27 papers), Platelet Disorders and Treatments (9 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Mindy Simpson is often cited by papers focused on Hemophilia Treatment and Research (27 papers), Platelet Disorders and Treatments (9 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Mindy Simpson collaborates with scholars based in United States, Germany and Italy. Mindy Simpson's co-authors include Leonard A. Valentino, Paul J. Carson, Ronald Schut, J A O'Brien, Neil A. Goldenberg, Lisa Boggio, Linda Jacobson, Lin Cong, William E. Hathaway and Géraldine S. Maro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Mindy Simpson

29 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mindy Simpson United States 12 308 83 47 40 40 31 392
M. von Depka Prondzinski Germany 7 306 1.0× 64 0.8× 50 1.1× 52 1.3× 17 0.4× 23 418
Johanna Konopacki France 8 97 0.3× 36 0.4× 18 0.4× 39 1.0× 23 0.6× 21 199
Mariagrazia Garzia Italy 8 76 0.2× 62 0.7× 68 1.4× 14 0.3× 19 0.5× 19 201
Wing-Yen Wong United States 10 599 1.9× 240 2.9× 43 0.9× 56 1.4× 10 0.3× 16 652
Vincenzo Nasillo Italy 10 66 0.2× 34 0.4× 30 0.6× 36 0.9× 26 0.7× 12 216
Shugo Kowata Japan 7 90 0.3× 27 0.3× 65 1.4× 39 1.0× 11 0.3× 26 181
Jean Maupas France 8 168 0.5× 33 0.4× 35 0.7× 47 1.2× 32 0.8× 14 281
Sophie Dimicoli United States 8 240 0.8× 57 0.7× 25 0.5× 123 3.1× 181 4.5× 14 393
Witold Prejzner Poland 10 237 0.8× 218 2.6× 21 0.4× 45 1.1× 17 0.4× 33 320
Chiara Frairia Italy 10 147 0.5× 90 1.1× 37 0.8× 86 2.1× 10 0.3× 24 296

Countries citing papers authored by Mindy Simpson

Since Specialization
Citations

This map shows the geographic impact of Mindy Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindy Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindy Simpson more than expected).

Fields of papers citing papers by Mindy Simpson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindy Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindy Simpson. The network helps show where Mindy Simpson may publish in the future.

Co-authorship network of co-authors of Mindy Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Mindy Simpson. A scholar is included among the top collaborators of Mindy Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mindy Simpson. Mindy Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reding, Mark T., Shadan Lalezari, Gili Kenet, et al.. (2024). Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review. Drugs in R&D. 24(3). 359–381. 3 indexed citations
3.
Young, Guy, Michael U. Callaghan, Vinod Balasa, et al.. (2023). Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A. Haemophilia. 29(5). 1234–1242. 1 indexed citations
6.
Pombar, Xavier, et al.. (2022). Persistent aneurysmal vitelline vein with thrombus successfully managed with anticoagulation. SHILAP Revista de lepidopterología. 78. 102179–102179. 1 indexed citations
7.
Kwak, Jenny, Michael Mazzeffi, Lisa Boggio, Mindy Simpson, & Kenichi A. Tanaka. (2020). Hemophilia: A Review of Perioperative Management for Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 36(1). 246–257. 12 indexed citations
8.
Lalezari, Shadan, et al.. (2020). Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc Analysis. Advances in Therapy. 37(6). 2763–2776. 1 indexed citations
9.
Mancuso, Maria Elisa, Mark T. Reding, Claude Négrier, et al.. (2020). Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis. Thrombosis and Haemostasis. 121(8). 1079–1086. 4 indexed citations
10.
Simpson, Mindy, et al.. (2020). Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products. Journal of Managed Care & Specialty Pharmacy. 26(4). 504–512. 14 indexed citations
11.
Ettingshausen, Carmen Escuriola, Inga Hegemann, Mindy Simpson, et al.. (2019). Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial. Research and Practice in Thrombosis and Haemostasis. 3(2). 268–276. 14 indexed citations
13.
Wang, Michael, Jeanne B. Lawrence, Doris Quon, et al.. (2017). PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding. Haemophilia. 23(6). 832–843. 26 indexed citations
14.
Ducore, Jonathan M., Jeanne B. Lawrence, Mindy Simpson, et al.. (2017). Safety and dose‐dependency of eptacog beta (activated) in a dose escalation study of non‐bleeding congenital haemophilia A or B patients, with or without inhibitors. Haemophilia. 23(6). 844–851. 13 indexed citations
15.
Lawrence, Jeffry B., Jacobus Burggraaf, Jonathan M. Ducore, et al.. (2016). A Phase Ib, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Coagulation Factor VIIa in Congenital Hemophilia A or B. 22. 68–68. 1 indexed citations
16.
Klamroth, Robert, Mindy Simpson, Joan Cox Gill, et al.. (2016). Comparative pharmacokinetics of rVIII‐SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A. Haemophilia. 22(5). 730–738. 42 indexed citations
17.
Simpson, Mindy & Leonard A. Valentino. (2012). Management of joint bleeding in hemophilia. Expert Review of Hematology. 5(4). 459–468. 42 indexed citations
18.
Valentino, Leonard A., et al.. (2011). Exploring the biological basis of haemophilic joint disease: experimental studies. Haemophilia. 18(3). 310–318. 52 indexed citations
19.
Simpson, Mindy, et al.. (2011). Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults. Thrombosis Research. 127(4). 317–323. 44 indexed citations
20.
Carson, Paul J., et al.. (1995). Antibody Class and Subclass Responses to Pneumococcal Polysaccharides following Immunization of Human Immunodeficiency Virus-Infected Patients. The Journal of Infectious Diseases. 172(2). 340–345. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026